Improving triage performance in emergency departments using machine learning and natural language processing: a systematic review
Abstract
In Emergency Departments (EDs), triage is crucial for determining patient severity and prioritizing care, typically using the Manchester Triage Scale (MTS). Traditional triage systems, reliant on human judgment, are prone to under-triage and over-triage, resulting in variability, bias, and incorrect patient classification. Studies suggest that Machine Learning (ML) and Natural Language Processing (NLP) could enhance triage accuracy and consistency. This review analyzes studies on ML and/or NLP algorithms for ED patient triage. Following Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines, we conducted a systematic review across five databases: Web of Science, PubMed, Scopus, IEEE Xplore, and ACM Digital Library, from their inception of each database to October 2023. The risk of bias was assessed using the Prediction model Risk of Bias Assessment Tool (PROBAST). Only articles employing at least one ML and/or NLP method for patient triage classification were included. Sixty studies covering 57 ML algorithms were included. Logistic Regression (LR) was the most used model, while eXtreme Gradient Boosting (XGBoost), decision tree-based algorithms with Gradient Boosting (GB), and Deep Neural Networks (DNNs) showed superior performance. Frequent predictive variables included demographics and vital signs, with oxygen saturation, chief complaints, systolic blood pressure, age, and mode of arrival being the most retained. The ML algorithms showed…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.